New Lancet series supports the inclusion of CVD and other NCDs in the post-2015 development agenda, aligning with World Heart Federation objectives

The new Lancet series, launched today, provides critical evidence to help support the World Heart Federation’s strategic objectives and its ambition to reduce premature cardiovascular disease (CVD) deaths by 25 per cent by 2025.

Produced by some of the world’s most eminent scientists and academics, including from within the World Heart Federation member network and committees, the Series provides the evidence for NCDs as a development issue and proposes cost-effective interventions to accelerate progress and avert millions of deaths worldwide. It also highlights the urgent need to include CVD and the other NCDs in the post-2015 development agenda and the new development goals being devised over the next 2 years by governments and the United Nations (UN).

Click here to read the full story.